GenMark Diagnostics, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$131.8M

1,301 transactions

Summary

GenMark Diagnostics, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $11.9MSales: $30.7M34 insiders

Date	Insider	Type	Value
2021-04-22	Mendel Scott(President & CEO)	U	$12.2M
2021-04-22	Gleeson Michael(SVP, Corp. Accounts)	U	$10.1M
2021-04-22	Ek John Frederick(Chief Financial Officer)	U	$5.6M
2021-04-22	Mendel Scott(President & CEO)	U	$2.8M
2021-04-22	Mendel Scott(President & CEO)	D	—
2021-04-22	Mendel Scott(President & CEO)	D	—
2021-04-22	Mendel Scott(President & CEO)	D	—
2021-04-22	Mendel Scott(President & CEO)	D	—
2021-04-22	Mendel Scott(President & CEO)	D	—
2021-04-22	Ek John Frederick(Chief Financial Officer)	D	—
2021-04-22	Ek John Frederick(Chief Financial Officer)	D	—
2021-04-22	Ek John Frederick(Chief Financial Officer)	D	—
2021-04-22	Ek John Frederick(Chief Financial Officer)	D	—
2021-04-22	Ek John Frederick(Chief Financial Officer)	D	—
2021-04-22	Gleeson Michael(SVP, Corp. Accounts)	D	—
2021-04-22	Gleeson Michael(SVP, Corp. Accounts)	D	—
2021-04-22	Gleeson Michael(SVP, Corp. Accounts)	D	—
2021-04-22	Gleeson Michael(SVP, Corp. Accounts)	D	—
2021-04-22	Gleeson Michael(SVP, Corp. Accounts)	D	—
2021-04-22	Gleeson Michael(SVP, Corp. Accounts)	D	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

GenMark Diagnostics, Inc. — Contributions, Lobbying & Contracts | Poliscope